인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2026.6
- 수록면
- 359 - 381 (23page)
이용수
초록· 키워드
BACKGROUND: Artificial sweeteners are widely used as sugar substitutes to reduce sugar intake and mitigate health risks. However, their potential long-term health effects remain uncertain as existing studies have reported inconsistent findings.
OBJECTIVE: This systematic review and meta-analysis aimed to examine the association between artificial sweetener intake and the risk of cardiometabolic outcomes and mortality.
METHODS: Studies were identified through comprehensive searches of PubMed and Embase up to October 8, 2025. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) comparing the highest and lowest artificial sweetener consumption categories were calculated using a random-effects model. Heterogeneity was assessed using the I² statistic. The methodological quality of the included studies was evaluated using the Newcastle–Ottawa Scale.
RESULTS: In total, 3,625,613 participants from 37 studies were included. Higher artificial sweetener intake was associated with an increased risk of type 2 diabetes (HR, 1.26; 95% CI, 1.14–1.40), hypertension (HR, 1.13; 95% CI, 1.09–1.18), heart failure (HR, 1.26; 95% CI, 1.14–1.39), stroke (HR, 1.12; 95% CI, 1.05–1.19), coronary artery disease (HR, 1.11; 95% CI, 1.00–1.23), cardiovascular mortality (HR, 1.18; 95% CI, 1.03–1.35), and all-cause mortality (HR, 1.09; 95% CI, 1.01–1.17). The association with atrial fibrillation was not significant (HR, 1.13; 95% CI, 0.94–1.37). Significant heterogeneity was observed for all endpoints except for stroke and heart failure.
CONCLUSIONS: This meta-analysis demonstrates that a higher intake of artificial sweeteners is associated with an increased risk of several cardiometabolic outcomes and mortality. These findings underscore the need for cautious consumption and further research into their cardiometabolic effects.
OBJECTIVE: This systematic review and meta-analysis aimed to examine the association between artificial sweetener intake and the risk of cardiometabolic outcomes and mortality.
METHODS: Studies were identified through comprehensive searches of PubMed and Embase up to October 8, 2025. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) comparing the highest and lowest artificial sweetener consumption categories were calculated using a random-effects model. Heterogeneity was assessed using the I² statistic. The methodological quality of the included studies was evaluated using the Newcastle–Ottawa Scale.
RESULTS: In total, 3,625,613 participants from 37 studies were included. Higher artificial sweetener intake was associated with an increased risk of type 2 diabetes (HR, 1.26; 95% CI, 1.14–1.40), hypertension (HR, 1.13; 95% CI, 1.09–1.18), heart failure (HR, 1.26; 95% CI, 1.14–1.39), stroke (HR, 1.12; 95% CI, 1.05–1.19), coronary artery disease (HR, 1.11; 95% CI, 1.00–1.23), cardiovascular mortality (HR, 1.18; 95% CI, 1.03–1.35), and all-cause mortality (HR, 1.09; 95% CI, 1.01–1.17). The association with atrial fibrillation was not significant (HR, 1.13; 95% CI, 0.94–1.37). Significant heterogeneity was observed for all endpoints except for stroke and heart failure.
CONCLUSIONS: This meta-analysis demonstrates that a higher intake of artificial sweeteners is associated with an increased risk of several cardiometabolic outcomes and mortality. These findings underscore the need for cautious consumption and further research into their cardiometabolic effects.
#Artificial sweeteners
#type 2 diabetes
#cardiovascular diseases
#mortality
#systematic review
#meta-analysis
상세정보 수정요청해당 페이지 내 제목·저자·목차·페이지정보가 잘못된 경우 알려주세요!
목차
- ABSTRACT
- INTRODUCTION
- METHODS
- RESULTS
- DISCUSSION
- REFERENCES